Short- and Long-Term Impact of Subtotal Parathyroidectomy on the Achievement of Bone and Mineral Parameters Recommended by Clinical Practice Guidelines in Dialysis Patients
NCT01872429 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 401
Last updated 2013-06-07
Summary
The impact of parathyroidectomy (PTX) on the bone mineral parameters in dialysis patients with secondary hyperparathyroidism (SHPT) remains unclear. The investigators performed this study to present the short- and long-term impact of PTX on calcium, phosphorus and intact parathyroid hormone control in dialysis patients with severe SHPT after operation. In particular, the investigators evaluate the impact based on the achievement of recommendations of the current clinical practice guidelines for bone and mineral parameters in dialysis patients after PTX.
Conditions
- Hyperparathyroidism
Sponsors & Collaborators
-
Far Eastern Memorial Hospital
lead OTHER
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-11-30
- Primary Completion
- 2013-04-30
- Completion
- 2013-04-30
Countries
- Taiwan
Study Locations
More Related Trials
-
the Study on Prognostic for Hemodialysis Patients
NCT03194087 ·Status: UNKNOWN
-
The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bone Mineral Density
NCT07171216 ·Status: RECRUITING ·Phase: NA
-
Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent Patients
NCT03937349 ·Status: COMPLETED
-
Study of the Influence of Dosages of 1-84 and 7-84 Fragments of Parathyroid Hormone Compared to Conventional Dosage on the Balance of Calcium and Phosphate in Hemodialysis (PTH)
NCT02859220 ·Status: COMPLETED ·Phase: NA
-
Study of 1.25 mmol/L Calcium Dialysate on Mineral Metabolism in Haemodialysis Patients.
NCT00744302 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Ultrasonic Ablation to Treat Secondary Hyperparathyroidism in Chronic Kidney Disease Patients
NCT01640184 ·Status: COMPLETED ·Phase: NA
-
Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients
NCT01447368 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Parathyroidectomy on Renal Function
NCT04798092 ·Status: UNKNOWN
-
Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients
NCT02684643 ·Status: COMPLETED ·Phase: NA
-
DePTH: De-emphasize PTH
NCT06288451 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Intravenous Paricalcitol in Chronic Hemodialysis Patients
NCT03023748 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness of Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients.
NCT02895061 ·Status: COMPLETED ·Phase: NA
-
The Longitudinal PTH-Study
NCT03464149 ·Status: COMPLETED
-
Parathyroid Hyperplasia in Patients With Chronic Kidney Disease.
NCT03182517 ·Status: UNKNOWN
-
Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis
NCT01785849 ·Status: COMPLETED ·Phase: PHASE3
-
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1
NCT05832931 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis
NCT01788046 ·Status: COMPLETED ·Phase: PHASE3
-
Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?
NCT00299572 ·Status: UNKNOWN ·Phase: PHASE4
-
The Influence of Low Phosphorus in Hemodialysis Patients
NCT04645459 ·Status: UNKNOWN ·Phase: NA
-
Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).
NCT04750460 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects
NCT00664430 ·Status: TERMINATED ·Phase: PHASE4
-
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2
NCT05836220 ·Status: COMPLETED ·Phase: PHASE3
-
Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment
NCT04637360 ·Status: COMPLETED ·Phase: NA
-
Low-Phosphate Diet and Fibroblast Growth Factor-23 Level
NCT03367338 ·Status: COMPLETED ·Phase: NA
-
Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease
NCT00285467 ·Status: COMPLETED ·Phase: NA